Navigation Links
DePuy ASR Hip Lawsuit News: New Case Substituted for Federal DePuy ASR Litigation’s First Bellwether Trial, Bernstein Liebhard LLP Reports
Date:7/12/2013

New York, New York (PRWEB) July 12, 2013

The U.S. District Judge presiding over thousands of DePuy ASR hip lawsuit claims filed in the U.S. District Court, Northern District of Ohio, has substituted a new case for the litigation’s first bellwether trial, Bernstein Liebhard LLP reports. According to an Order issued by Judge David A. Katz on July 8th, the opening date of the trial will remain September 9, 2013. Court documents indicate that the new bellwether case in the DePuy ASR litigation involves a Rochester, New York, patient who received one of the recalled implants in August 2009 and underwent revision surgery in January 2011. (McCracken v. DePuy Orthopaedics Inc., et al., No. 1:11-dp-2048)

“We look forward to the start of this trial in September. Many of the allegations made in this case echo those being put forth by our own DePuy ASR lawsuit clients,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices, including hundreds of clients in DePuy ASR lawsuits. The Firm continues to offer free legal evaluations to anyone who suffered serious complications associated with the DePuy ASR recall.

DePuy ASR Litigation
Court records indicate that more than 11,000 DePuy ASR lawsuits are pending in courts throughout the country, most of which have been filed in the multidistrict litigation being presided over by Judge Katz. All of the lawsuits allege the DePuy ASR, which was recalled in August 2010 due to an unacceptably high failure rate, was defectively designed and caused plaintiffs to suffer serious complications that resulted in early failure of the device, including metallosis, pain, and swelling. (In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation – MDL 2197)

While the trial in September will be the first in the federal litigation, two DePuy ASR lawsuit trials have already been held at the state level. In March, a plaintiff was awarded more than $8 million after a Los Angeles Superior Court jury found that the ASR was defectively designed. (Kransky v. DePuy, BC456086, California Superior Court, Los Angeles County) However, a jury in Chicago found for Johnson & Johnson in a second trial just one month later. (Strum v. DePuy, 2011-L-9352, Circuit Court of Cook County).

The DePuy ASR hip recall brought increased scrutiny on the entire class of metal-on-metal hips, and in February 2011, the U.S. Food & Drug Administration (FDA) began a safety review of such devices. In January 2013, the agency warned that metal-on-metal hips can shed dangerous amounts of metal debris in patients, leading to metallosis and other adverse local tissue reactions, pain and swelling, and ultimately premature failure of the device. The FDA has advised patients fitted with all-metal hips to undergo metal ion testing if they were experiencing signs or symptoms of device failure. The agency has also proposed new rules that would subject all-metal hips to greater regulatory oversight.*

Individuals affected by the DePuy ASR recall who allegedly suffered metallosis, premature device failure or other complications may be entitled to compensation for their medical bills, lost wages, pain and suffering, and other damages. A wealth of information regarding the DePuy ASR litigation is available on Bernstein Liebhard LLP’s website. For a free DePuy ASR lawsuit review, please contact one of our attorneys by calling 800-511-5092.

*fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm335775.htm?source=govdelivery, FDA, January 17, 2013

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
###

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.consumerinjurylawyers.com

Read the full story at http://www.prweb.com/releases/depuy-asr-hip-lawsuit/depuy-asr-lawsuit/prweb10924312.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DePuy Hip Replacement Lawsuit News: Lawsuit Chosen for First ASR Trial in Federal Court, Rottenstein Law Group LLP Reports
2. DePuy ASR Hip Recall News: Bernstein Liebhard LLP Comments on Irish Health Services Plan to Launch Major Review of Metal-on-Metal Hip Implants
3. DePuy ASR Lawsuits Progressing, Notes Rottenstein Law Group LLP
4. Arthrex, Depuy Mitek, and Smith & Nephew Lead the $1.5 Billion U.S. Orthopedic Soft Tissue Market, Reports iData Research
5. Bernstein Liebhard LLP Notes Plaintiffs’ Opposition to Defense Motion in Federal Litigation of DePuy Pinnacle Lawsuit Claims
6. US Drug Watchdog Now Calls Their DePuy Pinnacle Hip Implant Blood Test Initiative Vital And They Urge Recipients To Call Them For Instructions About This Important Test
7. US Drug Watchdog Now Urges All DePuy Pinnacle Hip Implant Recipients To Call Them For The Name Of A Special Blood Test To See If Their All Metal Hip Implant Has Failed
8. US Drug Watchdog Now Urges Recipients Of A DePuy Pinnacle All Metal Hip Implant To Call Them About A Vital Blood Test To See If Their Hip Implant Device Has Failed
9. DePuy Pinnacle Hip Replacement Lawsuit Filed by Wright & Schulte on Behalf of Ohio Man Who Required Revision Surgeries Allegedly Due to Pinnacle Hip Defects
10. DePuy ASR Hip Recall: Bernstein Liebhard LLP Comments on DePuy’s Motion to Strike Costs in Wake of $8.25 Million DePuy ASR Lawsuit Judgment
11. DePuy ASR Hip Implant Lawsuit Filed by Wright & Schulte on Behalf of Texas Man Who Alleges His Serious Hip Injuries Were Caused by Defective Design of ASR Hip Implant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... , ... February 27, 2017 , ... The threat of ... to work for a company involved in the underground testing of nuclear weapons. Years ... for Answers: Expendable Workers of the Cold War Nuclear Testing,” Clayton exposes the critical ...
(Date:2/27/2017)... ... 2017 , ... Orange County dentist, Dr. A. Rassouli, comments on ... when the bacteria in plaque infect the gums and other tissues supporting the teeth. ... planing or SRP, and can include surgical therapies if the condition has led to ...
(Date:2/27/2017)... ... February 26, 2017 , ... Miro is the ultimate smart media ... system brings songs, movies, TV shows and much more apps for user exploration. Its ... An immersive view of 1280 x 720 provides crisp images with remarkable clarity and ...
(Date:2/27/2017)... , ... February 27, 2017 , ... ... threshold mark last week. In addition, Discount Power's RCE (Residential Customer Equivalent) count ... in March 2014. The company had 800 customers and 2,250 RCEs at the ...
(Date:2/27/2017)... CA (PRWEB) , ... February 27, 2017 , ... ... for hair transplantation therapy, is proud to announce a new informational post on ... therapy procedures. Follicular Unit Extraction (FUE) hair transplant and Follicular Unit Transplantation (FUT) ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... Md. , Feb. 27, 2017  RegeneRx ... a clinical-stage drug development company focused on tissue ... licensee for RGN-137, GtreeBNT Co., Ltd., received a ... Phase 3 clinical trial design for RGN-137 to ... wound healing gel that incorporates Thymosin beta 4 ...
(Date:2/27/2017)... 27, 2017 A recent research report published ... market alone is expected to reach a value of $55.8 billion ... along with 28 states have legalized marijuana for medical uses. In ... Florida , North Dakota , ... to use the drug in medical applications such as chemotherapies and ...
(Date:2/27/2017)... N.J. and PETACH TIKVAH, Israel ... Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult ... appointments of June S. Almenoff , M.D., Ph.D., ... to its Board of Directors.  "Dr. ... executives whose appointments come at an exciting time for ...
Breaking Medicine Technology: